Nvidia Backs Recursion with $50M for AI-Powered Drug Discovery

Uncover the strategic move by Nvidia as they invest a substantial $50 million in Recursion, a pioneering force in AI-driven drug discovery. Delve into the potential innovations set to revolutionize the intersection of artificial intelligence and pharmaceuticals. Get on the AI Box Waitlist: https://AIBox.ai/Join our ChatGPT Community: https://www.facebook.com/groups/739308654562189/Follow me on Twitter: https://twitter.com/jaeden_ai See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.